Your browser doesn't support javascript.
loading
Kinetic response of wild and mutant core codon 70 strains of HCV genotype 1b to pegylated interferon-α and ribavirin therapy.
Hu, Zhongjie; Liu, Ying; Qiu, Lixia; Fan, Zuopeng; Nie, Wei; Liang, Shan; Jin, Ronghua.
Afiliação
  • Hu Z; Department of Hepatitis C & Toxic liver diseases, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. yfcyt@139.com.
  • Liu Y; Management center of medical record, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. lyhzj2006@126.com.
  • Qiu L; Department of Hepatitis C & Toxic liver diseases, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. jslygxc@sina.com.
  • Fan Z; Department of Hepatitis C & Toxic liver diseases, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. yunji8131@sina.com.
  • Nie W; Department of Hepatitis C & Toxic liver diseases, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. shuqing4000@sina.com.
  • Liang S; Department of Hepatitis C & Toxic liver diseases, Beijing Youan Hospital, Capital Medical University, Beijing, the People's Republic of China. cat216@163.com.
  • Jin R; Beijing Youan Hospital, Capital Medical University, No. 8 Xitoutiao, Youanmenwai, Fengtai District, Beijing, 100069, the People's Republic of China. jinronghua321@sina.com.
Virol J ; 12: 220, 2015 Dec 18.
Article em En | MEDLINE | ID: mdl-26684004
ABSTRACT

BACKGROUND:

Amino acid (aa) 70 substitution (R70Q/H) in the core protein of hepatitis C virus (HCV) genotype 1b has been shown to be one of the key factors in determining resistance for pegylated interferon-α plus ribavirin combination therapy (PEG-IFNα/RBV). But the exact mechanisms remain unclear. The aim of this study was to investigate the dynamic response of wild and mutant core codon 70 strains to PEG-IFNα/RBV treatment.

METHODS:

One hundred twelve Chinese patients with chronic HCV 1b infection were enrolled and received a standard protocol of 48 weeks of PEG-IFNα/RBV therapy and 24 consecutive weeks of follow-up. Serial blood samples were obtained at pretreatment baseline, and again at weeks 2, 4, 8, 12, and 24 during therapy for the quantification of 70R and 70Q/H strains. Dynamic characteristics and association with early virological response (EVR), sustained virological response (SVR) and IL28B genotypes were analyzed.

RESULTS:

Of the 112 patients enrolled in this study, 93.8% (105/112) were infected with mixture of 70R and 70Q/H strains before treatment. The 70Q/H strain was dominant in 20.5% of patients. 42.9% of patients with dominant 70Q/H exhibited EVR versus 88.6% of patients with dominant 70R (P < 0.001). Furthermore, 35.0% of patients with dominant 70Q/H exhibited SVR versus 77.4% with dominant 70R (P < 0.001). However, regardless of the dominant strain, virological response types or the IL28B SNP genotypes, 70Q/H strains always exhibited the same response to treatment as the 70R strains and the percentage of HCV harboring the 70Q/H substitution did not change significantly during treatment.

CONCLUSIONS:

Although the ratio of 70Q/H to 70R is related to the virological response, 70Q/H strains always exhibited the same response as the 70R strains during PEG-IFNα/RBV treatment. Substitution of R70Q/H alone is not enough to lead to resistance to therapy. Positive selection for 70Q/H induced by IFNα was not observed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Proteínas do Core Viral / Interferon-alfa / Hepacivirus / Hepatite C Crônica / Genótipo Tipo de estudo: Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Virol J Assunto da revista: VIROLOGIA Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Ribavirina / Proteínas do Core Viral / Interferon-alfa / Hepacivirus / Hepatite C Crônica / Genótipo Tipo de estudo: Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Virol J Assunto da revista: VIROLOGIA Ano de publicação: 2015 Tipo de documento: Article